Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Allscripts, Biogen, Celgene, Emovi, Genentech, Haliodx, Immunxperts, Kabafusion, Lincare, Luminex, Lung Therapeutics, Macopharma, Mahajan Imaging, Medical 2011, Medx Health, Mesa Biotech, Nexelis, Optikira, Orthopediatrics, Pixium Vision, Pliant Therapeutics, Respivant Sciences, SymphonyAI, SyntheticMR, Terarecon, Veradigm.

Med-tech firms raising money in public or private financings, including: Nanostring Technologies.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Acadia, Cytokinetics, Janssen, Lipocine, Neuren, Nucana, Zosano.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alopexx, Arcturus, Beijing Shenogen, BMS, Canndoc, Cellect, Epivax, Generex, Incyte, Insmed, Mallinckrodt, Morphosys, Nascent, Respirerx, Merck, Stada, Synedgen, Takeda, Voluntis.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alkermes, Allergan, American Brivision, Chugai, Cytodyn, Delmar, Discgenics, Editas, Innovent, Moderna, Oncolys.

Biopharmas raising money in public or private financings, including: Akari Therapeutics, Amunix Pharmaceuticals, Bridgebio Pharma, Cinclus Pharma Holding, Imara, Novan, Pacylex, Tonix, Vaxil, Zogenix.

New hires and promotions in the biopharma industry, including: Obsidian, Prothena, Relay.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Kyowa Kirin, Noxopharm, Shionogi, Takeda, Tessa, Ultragenyx.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Apeiron Biologics.

New hires and promotions in the biopharma industry in Asia-Pacific, including: Sumitomo Dainippon Pharma.